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Background: 
MNGIE is a rare and fatal inherited metabolic disorder due to a mutation in the nuclear 
TYMP gene leading to a deficiency in the enzyme thymidine phosphorylase. This 
subsequently causes an accumulation of the deoxynucleosides, thymidine, and 
deoxyuridine in tissues and body fluids, imbalances in the mitochondrial 
deoxyribonucleoside triphosphate pools and ultimately mitochondrial failure.  The 
understanding of the precise molecular mechanisms of this effect and how it influences 
disease phenotype is poorly understood. MicroRNAs are a class of small non-coding RNAs 
that regulate gene expression at the posttranscriptional level. The aberrant expression of 
miRNAs is implicated in a wide range of diseases; their study thus offers an approach to 
the elucidation of the underlying molecular mechanisms of disease pathology. 
Aims: 
To examine the expression profile of patient serum and serum derived exosomes with 
the aim of providing insight into the biochemical derangements which underlie the 
MNGIE phenotype. 
Methods: 
MicroRNA was extracted from patient and healthy control serum and serum-derived 
exosomes and profiled using Exiqon’s miCURY qPCR panel array. Differentially expressed 
miRNAs were subjected to bioinformatical analysis. 
Results: 
Compared to healthy controls, 53 and 22 up-regulated miRNAs were identified in patient 
serum and serum-derived exosomes, respectively. Cellular pathway enrichment analysis 
of the predicted target genes revealed over-representation of 8 pathways in serum, 
including the T cell receptor, adipocytokine, calcium and MAPK signalling pathways. In 
exosomes, the Jak-STAT signalling pathway was over-represented. A multiple miRNA 
target analysis revealed 8 and 6 predicted genes targets in serum and exosomes, 
respectively that were regulated simultaneously by 5 or more upregulated miRNAs. 
Conclusion:  
Expression profiling and bioinformatics analysis of serum-based miRNAs provides a 
powerful approach for elucidating potential gene targets and target pathways that are 
affected by deregulated miRNAs. 
